Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 30, 2012. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically detailing changes in share interests for Mrs. V A Whyte.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely records a specific transaction involving the exercise of share options and the subsequent sale and gifting of shares by a company officer.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a compliance notification under Disclosure Rule 3.1.4R(1)(a) and (c) regarding a transaction notified on November 29, 2012.
Important Facts for Investors
- Transaction Date: November 28, 2012.
- Individual Involved: Mrs. V A Whyte (Person Discharging Managerial Responsibility).
- Option Exercise: 7,800 Ordinary shares exercised at £11.79 per share (options granted December 3, 2002).
- Share Sale: 7,389 Ordinary shares sold at £13.34 per share.
- Share Gift: 411 Ordinary shares transferred as a gift to a connected person, Mr. I Whyte.
- Notification: The Company was advised of this transaction on November 29, 2012.